Form 4 for HCWB HCW Biologics Inc.
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-22 · accession 0001209191-21-048086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-23 | 2021-07-22 | HCWB | Medmira Capital Ltd. | 10% | C - Cnv Deriv | $0.00 | +3.59M | 2.86M | New | $0 |
| DM | 2021-07-23 | 2021-07-22 | HCWB | Medmira Capital Ltd. | 10% | C - Cnv Deriv | $0.00 | -3.59M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-22 | C | A | 730,519 | $0.00 | 3,587,661 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-22 | C | A | 2,857,142 | $0.00 | 2,857,142 | D | — | — | |
| 3 | Derivative | Series B Redeemable Preferred Stock | 2021-07-22 | C | D | 2,857,142 | $0.00 | 0 | D | — · — to — | 2,857,142 Common Stock | (F1) Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. |
| 4 | Derivative | Series C Redeemable Preferred Stock | 2021-07-22 | C | D | 730,519 | $0.00 | 0 | D | — · — to — | 730,519 Common Stock | (F2) Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. |